Rakesh Dixit

Vice President Research and Development and Global Head Biologics Safety, MedImmune
When
21st-22nd Jun 2018
Registration from 8am
Where
Boston, USA
Hilton Boston Back Bay
Global Engage is pleased to announce the Biologics & Biosimilars Congress: USA to be held in Boston, USA on June 21-22 2018.
Designed for experts working in a variety of exciting areas in biological therapeutics this conference will provide in-depth studies of antibody-based therapies, advances in immunotherapy and immuno-oncology, as well as developments in protein biotherapeutic considerations, techniques and technologies. Alongside this, our Biosimilars session will provide an opportunity to discuss the latest in the regulatory and commercial landscapes and a forum to examine the next steps in this ever-developing sector.
The Congress is expected to host over 50 presenters and several panel discussions and roundtable sessions, with opportunities for poster presentations, networking and 1-2-1 partnership meetings. This interactive meeting will provide the opportunity to keep up to date on the cutting edge of research and technology, new strategies and recent case study examples, and to forge lasting connections with other experts in your field.
2018 Speakers Include:
A key focus of this conference will be on recent developments in antibody-based therapeutics, including monoclonal and recombinant antibody design, as well as advances in ADC and bispecific antibody technology. Alongside antibody treatments in oncology, given the exciting developments in t-cell engineering and CAR-T therapies, this rapidly moving area will feature in our immunotherapy session. The protein biotherapeutics track explores a variety of topics in the development of biologics, including protein expression, novel scaffolds, and immunogenicity. Finally, our Biosimilars track will cover case studies as well as talks on IP and regulation.
Presentation by Ralf Schumacher, Global Head of Bioprocess and Pharmaceuticals Development, Boehringer Ingelheim
Director, Sterne, Kessler, Goldstein & Fox
Publisher & Executive Director, Journal of Antibody-Drug Conjugates
Partner, Schiff Hardin
Head of Bioassay, Teva Pharmaceuticals
Global Head, NBE Drug Disposition, EMD Serono
Director of Macromolecular Bioscience and Cancer Biology, SRI International
Research Investigator, Novartis
Senior Principal Scientist, Bristol-Myers Squibb
Senior Scientist, Xencor
Vice President Regulatory Affairs & Project Office, Medicago
CEO and President, Amunix
Head Antibody Generation Section, National Research Council Canada
Country Manager Serbia, Astellas
Senior Scientist, MedImmune
CEO & Founder, Ossianix
Chief Scientific Officer, Adello Biologics
Head of Research, Merrimack Pharmaceuticals
Vice President Research and Development and Global Head Biologics Safety, MedImmune
CSO, Coriolis Pharma
Head of Biopharmaceuticals, Sandoz
Director, Sterne, Kessler, Goldstein & Fox
Publisher & Executive Director, Journal of Antibody-Drug Conjugates
Partner, Schiff Hardin
Head of Bioassay, Teva Pharmaceuticals
Global Head, NBE Drug Disposition, EMD Serono
Director of Macromolecular Bioscience and Cancer Biology, SRI International
Research Investigator, Novartis
Senior Principal Scientist, Bristol-Myers Squibb
Senior Scientist, Xencor
Vice President Regulatory Affairs & Project Office, Medicago
CEO and President, Amunix
Head Antibody Generation Section, National Research Council Canada
Country Manager Serbia, Astellas
Senior Scientist, MedImmune
CEO & Founder, Ossianix
Chief Scientific Officer, Adello Biologics
Head of Research, Merrimack Pharmaceuticals
Vice President Research and Development and Global Head Biologics Safety, MedImmune
CSO, Coriolis Pharma
Head of Biopharmaceuticals, Sandoz
This US meeting will provide in-depth studies of antibody-based therapies, advances in immunotherapy and immuno-oncology, as well as developments in protein biotherapeutic considerations, techniques and technologies. Alongside this, our Biosimilars session will provide an opportunity to discuss the latest in the regulatory and commercial landscapes and a forum to examine the next steps in this ever-developing sector.
Download the AgendaGet news about new biologics research and applications direct to your inbox.
Hilton Boston Back Bay
40 Dalton St, Boston,
MA 02115, USA
3 for the price of 2 offer
Discount applied automatically when registering 3 places at once.
Not applicable for solution provider companies or compatible with any other offers or discount codes.
Option 1 – Please phone +44 (0) 1865 849841 and we will take your details over the phone
Option 2 – Please complete the form below to pay online
Poster presentation sessions will take place in breaks and alongside the other breakout sessions of the conference. Your presentation will be displayed in a dedicated area, with the other accepted posters from industry and academic presenters.
We also issue a poster eBook to all attendees with your full abstract in and can share your poster as a PDF after the meeting if you desire (optional).
Whether looking for funding, employment opportunities or simply wanting to share your work with a like-minded and focused group, these are an excellent way to join the heart of this congress.
In order to present a poster at the forum you need to be registered as a delegate. Please note that there is limited space available and poster space is assigned on a first come first served basis (subject to checks and successful registration).
We charge an admin fee of $100 to industry delegates to present, that goes towards the shared cost of providing the poster presentation area and display boards, guides etc. This fee is waived for those representing academic institutions and not for profit organisations.
Submission instructions
We will require the form (downloadable below) to be submitted by the 8th June. This is the formal deadline however space is another limiting factor so early application is recommended. Therefore please contact us with any questions you have as soon as possible.
Our sponsorship packages offer a wide range of attendance options to suit your budget and business needs in order to maximise return on investment.
If there is any other way you would like to sponsor or increase branding for your company at the event, please get in touch and we will be able to offer you a bespoke service.
Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings, held during breakout sessions from the main conference agenda. Our conference team will be available at the sessions to ensure all your meetings take place on time.
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience
Market to our event database and / or increase brand awareness through taking a poster position or sponsoring one of the refreshment breaks, lunches, drinks receptions or poster sessions. This can be supplemented by branding options such as placing your logo on the attendee lanyards or conference bags.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas where all refreshment breaks and lunches take place, as well as the networking drinks reception at the end of day one.
Options include:
30-minute speaker presentations
Chairing / panellist positions during a 30-minute panel discussion
Hosting a 1-hour workshop within the conference program
For further details please contact
Gavin Hambrook/ Nick Best
Telephone +44 (0) 1865 849841 or
email [email protected]
Call us on +44 (0)1865 849 841
For details on attendees, packages and new opportunities, please contact our sponsorship team who will quickly provide everything you need to assess the conference for yourself.
We are a creative events marketing firm that will assist you in ensuring that your endeavors are successful. With a combination of utilizing our robust experience in the industry, professional methods, immense enthusiasm and technology, we are assisting in delivering the best service possible to our esteemed clients.
×American Pharmaceutical Review is a journal covering the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies
×Global Information, Inc. is an information service company holding offices in 6 countries and have sales agency contracts with over 300 research companies around the world. We sell 30,000 market research reports published by these publishers and accept custom-made researches.
×IJCBDD, an International Society of Intelligent Biological Medicine official journal, bridges the gap between two very important, complementary disciplines, computational biology and drug design. Through advances in high-throughput genome sequencing and digital imaging technologies, biocomputing, drug design and medical research have unfolded new, predictive sciences such as genomics, proteomics, lipidomics, metabolomics, cytomics and pharmaconomics. These promote new computational, statistical and biomedical approaches to drug design/development, besides unleashing the potential of significantly more accurate, effective personalised diagnosis, therapeutics and patient care.
×IJCIH is a fully-refereed international journal publishing original articles concerning the theory and application of the computer to biomedicine and healthcare, with emphasis on novel approaches of wide healthcare significance.
×Mining bioinformatics data is an emerging area at the intersection between bioinformatics and data mining. The objective of IJDMB is to facilitate collaboration between data mining researchers and bioinformaticians by presenting cutting edge research topics and methodologies in the area of data mining for bioinformatics. This perspective acknowledges the inter-disciplinary nature of research in data mining and bioinformatics and provides a unified forum for researchers/practitioners/students/policy makers to share the latest research and developments in this fast growing multi-disciplinary research area.
×Facilitating transformation from data to information to knowledge is paramount for organisations. Companies are flooded with data and conflicting information, but with limited real usable knowledge. However, rarely should a process be looked at from limited angles or in parts. Isolated islands of data mining, modelling and management (DMMM) should be connected. IJDMMM highlightes integration of DMMM, statistics/machine learning/databases, each element of data chain management, types of information, algorithms in software; from data pre-processing to post-processing; between theory and applications.
×IJMEI promotes an understanding of the structural/functional aspects of disease mechanisms and the application of technology towards the treatment/management of such diseases. It seeks to promote interdisciplinary collaboration between those interested in the theoretical and clinical aspects of medicine and to foster the application of computers and mathematics to problems arising from medical sciences. IJMEI includes authoritative review papers, the reporting of original research, and evaluation reports of new/existing techniques and devices. Each issue also contains a comprehensive information service.
דIn the realm of Pharmacy, where innovation is rapid, Pharmaceutical-Tech stands adept at conceptualizing unique ideas relevant to the B2B space. Pharmaceutical-Tech is essentially a B2B online business, technology media platform and global magazine that have under its wraps the largest global database of Pharmacy buyers and suppliers.
×Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.
Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world.
Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.
×Pink Medico – Medical and Healthcare Magazine (Print & Digital Version). We educate and empower consumers through our portal with latest news and trends, updates of medical and healthcare providers, pharma companies, new research and technologies, Medical Tourism… We are a revolutionary medical and healthcare aggregator that supports complete healthcare and allied services. We create a 360-degree approach towards quality healthcare service and ensure a wide range of people understand and avail healthcare easily. We are also NABH (National Accreditation Board for Hospitals and Healthcare Providers, India) Accredited Medical Tourism Facilitator.
×Sign up to receive updates, news and speaker resources
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.